BEAUTY CLINIC

PROFHILO TREATMENT

What is PROFHILO?

Profhilo is the first BDDE-free stabilised injectable hyaluronic acid (HA) based product for
treating skin laxity.

With one of the highest concentrations of HA on the market (64mg / 2ml) it is not only boosting
and hydrating the skin, but also remodels the ageing and sagging tissue.

Profhilo delivers great results as a treatment on its own or in combination with other aesthetics
treatments currently on offer.

HOW DOES PROFHILO WORK?

As a stabilised product Profhilo lasts in the skin around 28 days. During this time the stimulation
of 4 different types of collagen and elastin takes place by slow release of HA.

The stimulation results in significant tissue improvement. Therefore we cannot say that Profhilo is a skin booster as it also has a significant tightening/lifting effect on the tissue.

UNIQUE PRODUCT

There are many characteristics that make Profhilo unique from anything else available on the market right now. There is no BDDE content. It is thermally cross-linked generating stabilised
hybrid co-operative complexes of H-HA and L-HA. 

Despite its high HA content, it has a low
inflammatory profile coupled with pro-healing properties backed by clinical studies.

To fully understand this new concept in anti-ageing medicine we have to take a look at the technology
first.

HIGHEST CONCENTRATION ON THE MARKET

Profhilo contains 32mg of low molecular weight HA (80-100Kda) and 32 mg of high molecular weight HA (1100-1400Kda). This gives one of the highest concentration of HA on the market totalling 64 mg of HA in a 2ml prefilled syringe.

What is the cost?

£190 per treatment or £350 for a course of 2
Profhilo generally requires 2 treatments spaced 30days apart

Profhilo-ewa-bogumil-clinic

BAP TECHNIQUE

To maximise the diffusion in the malar and sub-malar areas:

  • The BAP were specifically chosen in anatomically respective areas
  • The dilution phenomenon of the product itself
  • 5 injections per side
  • Reduced pain (slow injection)
  • Lower possibility of bruising or hematoma
  • Reduced number of treatment sessions
  • Greater patient compliance